We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 38 of 125 for:    fibromyalgia | Recruiting, Not yet recruiting, Available Studies

Laughter Frequency and Fibromyalgia Symptoms (LAF)

This study is currently recruiting participants.
Verified November 2016 by Deidre Molchan, Walden University
Sponsor:
ClinicalTrials.gov Identifier:
NCT02957110
First Posted: November 7, 2016
Last Update Posted: November 7, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Deidre Molchan, Walden University
  Purpose
The purpose of this study is to investigate whether daily laughter frequency is associated with pain intensity and emotional state ratings in individuals who have fibromyalgia syndrome.

Condition Intervention
Fibromyalgia Behavioral: Laughter Frequency

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: The Relationships Between Laughter Frequency, Pain Perception, and Affect in Fibromyalgia Patients

Resource links provided by NLM:


Further study details as provided by Deidre Molchan, Walden University:

Primary Outcome Measures:
  • Laughter Frequency [ Time Frame: 14 days ]
    Documenting each instance of laughter throughout each day.

  • Pain Ratings [ Time Frame: Three times per day for 14 days ]
    Rating overall pain from 0 to 10, three times daily

  • Emotional State [ Time Frame: Three times per day for 14 days ]
    Rating momentary emotional state three times per day


Estimated Enrollment: 62
Study Start Date: November 2016
Estimated Study Completion Date: August 2017
Estimated Primary Completion Date: August 2017 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Laughter Frequency
    Relationships between laughter frequency, momentary mood state, and pain will be observed.
Detailed Description:

Participants will be asked to provide (or authorize the researcher to obtain) fibromyalgia diagnosis confirmation from a health care provider.

Initially, participants will complete a demographics form and two screening assessments. Then for 14 days, they will be asked to rate their momentary mood and overall pain levels three times per day (shortly after waking up, around 3:00 p.m., and at about an hour before bedtime). At the same time, they will be asked to log each instance of laughter as it occurs, daily, for 14 days. They will carry the log with them throughout each day in order to document each instance of laughter.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Individuals who have been diagnosed with fibromyalgia syndrome.
Criteria

Inclusion Criteria:

  • Individuals who have fibromyalgia syndrome

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02957110


Contacts
Contact: Deidre G Molchan, M.A. 703-967-0609 deidre.molchan@waldenu.edu

Locations
United States, Minnesota
Walden University Recruiting
Minneapolis, Minnesota, United States, 55401
Contact: Deidre G Molchan, M.A.    703-967-0609    deidre.molchan@waldenu.edu   
Sponsors and Collaborators
Walden University
Investigators
Study Chair: Ellen Levine, PhD Walden University
  More Information

Responsible Party: Deidre Molchan, Doctoral Student, Walden University
ClinicalTrials.gov Identifier: NCT02957110     History of Changes
Other Study ID Numbers: 08-05-16-0146047
First Submitted: November 2, 2016
First Posted: November 7, 2016
Last Update Posted: November 7, 2016
Last Verified: November 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Additional relevant MeSH terms:
Fibromyalgia
Myofascial Pain Syndromes
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases